Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03179280Completed
Randomised, open-label trial of insulin aspart in type 1 diabetes mellitus (T1D) (2 arms), sponsored by Aristotle University of Thessaloniki. Primary endpoint: Post-prandial euglycaemia at 6 hours. Started Mar 2011; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03179280.